Substituting BCNU by thiotepa in the conditioning regimen of patients with lymphomas undergoing an autologous stem cell transplantation (team protocol). The experience of one centre

被引：0
|
作者：
Maw, D. [1 ]
Jansen, A. [1 ]
Sims, H. [1 ]
Crawley, C. [1 ]
Sureda, A. [1 ]
机构：
[1] Addenbrookes Hosp, Cambridge, England
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [41] Thiotepa-treosulfan-fludarabine (ttf) as conditioning regimen in patients undergoing allogeneic hematopoietic stem cell transplantation (allohsct) for myelofibrosis or myelodysplastic syndrome: A single center experience
    Canale, F. A.
    Porto, G.
    Provenzano, P. F.
    Naso, V.
    Moscato, T.
    Pugliese, M.
    Loteta, B.
    Irrera, G.
    Console, G.
    Ferreri, A.
    Martino, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 236 - 236
  • [42] Intravenous busulfan as part of conditioning regimen in children undergoing allogeneic and autologous haematopoietic stem cell transplantation
    Gomez-Garcia, L.
    Molina, J. R.
    Rodriguez, G.
    Rodriguez-Villa, A.
    Garcia, E.
    Buenasmananas, D.
    Llamas, M. J.
    Chic, C.
    Rojas, R.
    Carmen, M.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [43] Outcome of lymphoma patients undergoing autologous stem cell transplantation in a single centre
    Torbagyi, E
    Barta, A
    Lengyel, L
    Poros, A
    BONE MARROW TRANSPLANTATION, 2005, 35 : S245 - S245
  • [44] Autologous stem cell transplantation with thiotepa-based conditioning in patients with systemic sclerosis and cardiac manifestations
    Henes, Joerg C.
    Koetter, Ina
    Horger, Marius
    Schmalzing, Marc
    Mueller, Karin
    Eick, Christian
    Bauer, Axel
    Vogel, Wichard
    Kanz, Lothar
    RHEUMATOLOGY, 2014, 53 (05) : 919 - 922
  • [45] Thiotepa-busulfan-fludarabine as a conditioning regimen for patients with myelofibrosis undergoing allogeneic hematopoietic transplantation: a single center experience
    Memoli, Mara
    Paviglianiti, Annalisa
    Malard, Florent
    Battipaglia, Giorgia
    Brissot, Eolia
    Mediavilla, Clemence
    Bianchessi, Antonio
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Lapusan, Simona
    Hirsch, Pierre
    Favale, Fabrizia
    Boussaroque, Agathe
    Bonnin, Agnes
    Vekhoff, Anne
    Legrand, Ollivier
    Mohty, Mohamad
    Dulery, Remy
    LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 419 - 427
  • [46] Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience
    Alimohamed, Nimira
    Daly, Andrew
    Owen, Carolyn
    Duggan, Peter
    Stewart, Douglas A.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 862 - 867
  • [47] Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
    Brunstein, Claudio G.
    Pasquini, Marcelo C.
    Kim, Soyoung
    Fei, Mingwei
    Adekola, Kehinde
    Ahmed, Ibrahim
    Aljurf, Mahmoud
    Agrawal, Vaibhav
    Auletta, Jeffrey J.
    Battiwalla, Minoo
    Bejanyan, Nelli
    Bubalo, Joseph
    Cerny, Jan
    Chee, Lynette
    Ciurea, Stefan O.
    Freytes, Cesar
    Gadalla, Shahinaz M.
    Gale, Robert Peter
    Ganguly, Siddhartha
    Hashmi, Shahrukh K.
    Hematti, Peiman
    Hildebrandt, Gerhard
    Holmberg, Leona A.
    Lahoud, Oscar B.
    Landau, Heather
    Lazarus, Hillard M.
    de Lima, Marcos
    Mathews, Vikram
    Maziarz, Richard
    Nishihori, Taiga
    Norkin, Maxim
    Olsson, Richard
    Reshef, Ran
    Rotz, Seth
    Savani, Bipin
    Schouten, Harry C.
    Seo, Sachiko
    Wirk, Baldeep M.
    Yared, Jean
    Mineishi, Shin
    Rogosheske, John
    Perales, Miguel-Angel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03) : 480 - 487
  • [48] Autologous stem cell transplantation in elderly patients with multiple myeloma (≥ 65 years).: The experience of one centre
    Garcia Guinon, A.
    Sureda, A.
    Martino, R.
    Valcarcel, D.
    Briones, J.
    Delgado, J.
    Pinana, J. L.
    Sanchez-Gonzalez, B.
    Brunet, S.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S157 - S158
  • [49] Conditioning regimen with cisplatin (PEAM) versus carmustine-BCNU (BEAM) followed by autologous haematopoietic stem cell transplantation in lymphoma
    Padilla-Ortega, J. A.
    Acosta-Maldonado, B. L.
    Rivera-Fong, L.
    Zazueta-Pozos, J. F.
    Ladines-Castro, W. J.
    Dulon-Tarqui, J. E.
    Valero-Saldana, L. M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S324 - S325
  • [50] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
12345